Argentarii’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$597K Sell
2,441
-346
-12% -$80.6K 0.21% 99
2025
Q4
$577K Buy
2,787
+9
+0.3% +$1.78K 0.19% 106
2025
Q3
$515K Sell
2,778
-17
-0.6% -$2.91K 0.21% 89
2025
Q2
$427K Sell
2,795
-80
-3% -$12.3K 0.2% 95
2025
Q1
$477K Buy
2,875
+40
+1% +$6.26K 0.24% 91
2024
Q4
$410K Buy
+2,835
New +$439K 0.21% 95

Other funds holding JNJ

Argentarii's JNJ Position: Q1 2026 in Review

Argentarii reduced its Johnson & Johnson (JNJ) stake by 12% in Q1 2026, selling an estimated $80.6K and leaving 2,441 shares worth $597K. The position accounts for 0.21% of the portfolio, ranked #99.

Argentarii first reported a position in JNJ in Q4 2024 and has held it in 6 quarters since. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Argentarii held 2,441 shares of Johnson & Johnson worth $597K as of Q1 2026.
  • Argentarii sold 346 Johnson & Johnson shares in Q1 2026, an estimated $80.6K.
  • Johnson & Johnson made up 0.21% of Argentarii's portfolio in Q1 2026, its #99 holding.
  • Argentarii first reported a position in Johnson & Johnson in Q4 2024 and has held it in 6 quarters since.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Argentarii's 13F filing for Q1 2026, filed 12 May 2026.